These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37877627)

  • 21. Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison.
    Chen CT; Lu MY; Hsieh MH; Tsai PC; Hsieh TY; Yeh ML; Huang CI; Tsai YS; Ko YM; Lin CC; Chen KY; Wei YJ; Hsu PY; Hsu CT; Jang TY; Liu TW; Liang PC; Hsieh MY; Lin ZY; Huang CF; Huang JF; Dai CY; Chuang WL; Shih YL; Yu ML
    World J Gastroenterol; 2022 Jan; 28(2):263-274. PubMed ID: 35110949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study.
    Adjei AA; Armah HB; Gbagbo F; Ampofo WK; Boamah I; Adu-Gyamfi C; Asare I; Hesse IF; Mensah G
    BMC Infect Dis; 2008 Mar; 8():33. PubMed ID: 18328097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Screening and treatment of hepatitis C virus in prisons: 10 years of experience].
    Werling K; Makara M; Nemesi K; Horváth G; Schneider F; Bali I; Enyedi J; Jancsik V; Káfony A; Lesch M; Lombay B; Müller Z; Ozsvár Z; Patai Á; Péterfi Z; Pusztay M; Szabó O; Szlávik J; Tóth T; Varga M; Gács J; Újhelyi E; Nemes Nagy A
    Orv Hetil; 2022 May; 163(22):871-878. PubMed ID: 35895613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.
    Crowley D; Murtagh R; Cullen W; Keevans M; Laird E; McHugh T; McKiernan S; Miggin SJ; O'Connor E; O'Reilly D; Betts-Symonds G; Tobin C; Van Hout MC; Lambert JS
    Harm Reduct J; 2019 Jul; 16(1):42. PubMed ID: 31277665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England.
    Mohamed Z; Al-Kurdi D; Nelson M; Shimakawa Y; Selvapatt N; Lacey J; Thursz MR; Lemoine M; Brown AS
    Int J Drug Policy; 2020 Jan; 75():102608. PubMed ID: 31759307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
    He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J
    Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County.
    Gahrton C; Westman G; Lindahl K; Öhrn F; Dalgard O; Lidman C; Nilsson LH; Said K; Duberg AS; Aleman S
    BMC Infect Dis; 2019 Nov; 19(1):955. PubMed ID: 31706284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users.
    Kim AY; Nagami EH; Birch CE; Bowen MJ; Lauer GM; McGovern BH
    Hepatology; 2013 Mar; 57(3):944-52. PubMed ID: 23111904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatitis C in prison settings: screening and therapy are improving. Comparative survey between 2000 and 2003].
    Remy AJ;
    Presse Med; 2006 Sep; 35(9 Pt 1):1249-54. PubMed ID: 16969313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework.
    Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C
    Addiction; 2023 Jun; 118(6):1153-1160. PubMed ID: 36683132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solving the Gap Between HCV Detection and Treatment in Prison HCVRNA Testing and Treatment in a Cohort of Newly Arrived Convicts in Southern Italy.
    Izzo C; Masarone M; Torre P; Melara G; De Matteis G; De Luna A; Pagano AM; Persico M
    Rev Recent Clin Trials; 2021; 16(4):396-402. PubMed ID: 34126911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing assessment and treatment of hepatitis C in the custodial setting.
    Post JJ; Arain A; Lloyd AR
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S70-4. PubMed ID: 23884069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study of rapid hepatitis C virus testing in the Rhode Island Department of Corrections.
    Beckwith CG; Kurth AE; Bazerman LB; Patry EJ; Cates A; Tran L; Noska A; Kuo I
    J Public Health (Oxf); 2016 Mar; 38(1):130-7. PubMed ID: 25736438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence, prevalence and risk factors for hepatitis C in Danish prisons.
    Søholm J; Holm DK; Mössner B; Madsen LW; Hansen JF; Weis N; Sauer AP; Awad T; Christensen PB
    PLoS One; 2019; 14(7):e0220297. PubMed ID: 31348813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.
    Crowley D; Lambert JS; Betts-Symonds G; Cullen W; Keevans M; Kelly E; Laird E; McHugh T; McKiernan S; Miggin SJ; Murphy C; Murtagh R; O'Reilly D; Tobin C; Van Hout MC
    Euro Surveill; 2019 Apr; 24(14):. PubMed ID: 30968825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus recommendations on the management of hepatitis C in Australia's prisons.
    Winter RJ; Sheehan Y; Papaluca T; Macdonald GA; Rowland J; Colman A; Stoove M; Lloyd AR; Thompson AJ
    Med J Aust; 2023 Mar; 218(5):231-237. PubMed ID: 36871200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.
    Skipper C; Guy JM; Parkes J; Roderick P; Rosenberg WM
    Gut; 2003 Oct; 52(10):1500-4. PubMed ID: 12970145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting.
    Sharafi H; Poustchi H; Azimian F; Tamadoni B; Ramezani R; Gouya MM; Sheikh M; Hashemi F; Tashakorian M; Alasvand R; Alavian SM; Merat S
    J Clin Virol; 2019 Apr; 113():20-23. PubMed ID: 30825832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixed-methods evaluation of point-of-care hepatitis C virus RNA testing in a Scottish prison.
    Byrne CJ; Malaguti A; Inglis SK; Dillon JF
    BMJ Open; 2023 Apr; 13(4):e068604. PubMed ID: 37037621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevalence of hepatitis B and C among prison population in Croatia].
    Burek V; Horvat J; Susić E; Mikulić R
    Acta Med Croatica; 2009 Dec; 63(5):447-50. PubMed ID: 20198906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.